AIM
MED icon

Arcadia Investment Management’s Medifast MED Stock Holding History

Arcadia Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,861
Closed -$202K – 352
2022
Q3 		$202K Buy
1,861
+388
+26% +$55.6K 0.05% 124
2022
Q2 		$266K Buy
1,473
+195
+15% +$34.9K 0.06% 118
2022
Q1 		$218K Sell
1,278
-549
-30% -$103K 0.04% 130
2021
Q4 		$383K Buy
1,827
+556
+44% +$115K 0.06% 113
2021
Q3 		$245K Buy
1,271
+1,039
+448% +$255K 0.05% 127
2021
Q2 		$66K Buy
232
+215
+1,265% +$58.3K 0.01% 185
2021
Q1 		$4K Buy
+17
New +$4.07K ﹤0.01% 267

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Arcadia Investment Management's MED Position: Q4 2022 in Review

Arcadia Investment Management sold out of Medifast (MED) in Q4 2022, closing a stake of 1,861 shares — an estimated $202K sold.

Arcadia Investment Management first reported a position in MED in Q1 2021 and held it in 7 quarters. The position peaked at $383K in Q4 2021. 277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

  • Arcadia Investment Management reported no remaining Medifast position as of Q4 2022 after selling out during the quarter.
  • Arcadia Investment Management sold 1,861 Medifast shares in Q4 2022, an estimated $202K.
  • Arcadia Investment Management first reported a position in Medifast in Q1 2021 and held it in 7 quarters.
  • Arcadia Investment Management's Medifast position peaked at $383K in Q4 2021.
  • 277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on Arcadia Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.